Ra Medical has re-upped its registration for an upcoming initial public offering looking to bring in approximately $86.3 million, according to a recently posted SEC filing.
Ra Medical produces the Dabra atherectomy catheter laser designed to treat patients with peripheral artery disease. The system is designed to destroy arteriosclerotic blockages through the use of radiation ablation, which the company touts as having significant advantages over traditional balloon angioplasty systems.
The Carlsbad, Calif.-based company originally registered for the IPO in July, saying it plans to list on the New York Stock Exchange under the symbol “RMED,” according to the filing.
Piper Jaffray and Cantor Fitzgerald are acting as joint book runners for the offering, according to the newly posted filing.
The company has not yet released details on the IPO, but had initially planned to launch the offering in February this year.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.